OTCM
CNGGF
Market cap2mUSD
Jun 18, Last price
0.00USD
Name
Cann Group Ltd
Chart & performance
P/E
0.17
P/S
0.40
EPS
0.03
Vol. 1Y
—
Shs. 5Y
36.25%
Rev. 5Y
14.81%
Div Yld LY
—
Div Yld TTM
—
Revenues
9m
-35.39%
Net income
20m
P
CFO
-1m
L-86.21%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of therapeutic cannabis products. The company supplies these products for use within Australia and also exports them to international markets, operating under specific licenses that permit research and the cultivation of cannabis for human medicinal and scientific purposes.
Key people
Interim Non-Executive Chairman of the Board · since 2025
Shane Duncan
Chief Operating Officer
Jenni Pilcher
Chief Executive Officer, Managing Director, Executive Director · since 2024
Steven Notaro
Company Secretary · since 2024
Peter Kopanidis
Director · since 2025
Non-Executive Director · since 2022
Legal address
Walter & Eliza Hall Institute Building, 4 Research Avenue
Bundoora, VIC 3083
AU
Bundoora, VIC 3083
AU
Headquarters
Walter & Eliza Hall Institute Building, 4 Research Avenue
Bundoora, VIC 3038
AU
Bundoora, VIC 3038
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||